Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Xenon Pharmaceuticals drops 27.5% pre-market after suspending enrollment for depression drug trial

Xenon Pharmaceuticals drops 27.5% pre-market after suspending enrollment for depression drug trial

智通财经智通财经2026/09/18 08:26
Show original
Xenon Pharmaceuticals fell 27.5% in U.S. pre-market trading after the company suspended new patient enrollment in its depression drug trial.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!